翻訳と辞書 |
Nomenclature of monoclonal antibodies : ウィキペディア英語版 | Nomenclature of monoclonal antibodies
The nomenclature of monoclonal antibodies is a naming scheme for assigning generic, or nonproprietary, names to monoclonal antibodies. An antibody is a protein that is produced in B cells and used by the immune system of humans and other vertebrate animals to identify a specific foreign object like a bacterium or a virus. ''Monoclonal'' antibodies are those that were produced in identical cells, often artificially, and so share the same target object. They have a wide range of applications including medical uses.〔 This naming scheme is used for both the World Health Organization’s International Nonproprietary Names (INN)〔 and the United States Adopted Names (USAN)〔 for pharmaceuticals. In general, word stems are used to identify classes of drugs, in most cases placed word-finally. All monoclonal antibody names end with the stem ''-mab''. Unlike most other pharmaceuticals, monoclonal antibody nomenclature uses different preceding word parts (morphemes) depending on structure and function. These are officially called ''substems'' and sometimes erroneously ''infixes'', even by the USAN Council itself.〔 ==Components==
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Nomenclature of monoclonal antibodies」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|